| Document |
Document Title |
|
WO/2022/183900A1 |
Disclosed in the present invention is an organic light-emitting device having a thermally activated delayed fluorescent material as a light-emitting layer material. The thermally activated delayed fluorescent material comprises one of a ...
|
|
WO/2022/181439A1 |
The purpose of the present invention is to provide: a compound that has high thermal stability, that has a principal absorption band in the near-infrared light range of 900 nm and above which can easily be used in organic electronic devi...
|
|
WO/2022/182721A1 |
The present disclosure relates to novel photoluminescent complexes comprising a BODIPY moiety covalently bonded to a blue light absorbing moiety, a color conversion film comprising the photoluminescent complex, and a back-light unit usin...
|
|
WO/2022/182993A1 |
Described are liposomal formulation for the improved delivery of boronic acid esters of boronic acid therapeutic agents. The liposomal formulation can include (i) liposomes formed from a vesicle-forming lipid; and (ii) a capturing agent-...
|
|
WO/2022/176543A1 |
A problem addressed by the present invention is to provide: a triarylboron compound that has the property of emitting light by thermally activated delayed fluorescence and has excellent thermal stability and chemical stability; and an or...
|
|
WO/2022/174503A1 |
The present application provides a preparation method for trimethylaluminum, comprising the steps of: in the presence of a catalyst and a solvent, methylaluminum dichloride or methylaluminum sesquichloride or dimethylaluminum chloride re...
|
|
WO/2022/176961A1 |
Disclosed is a compound represented by formula (1). In formula (1), n represents an integer of 0-5. Q1, Q2, Q3, and Q4 represent a moiety selected from group A, a moiety selected from group B, a moiety represented by formula (C1), or the...
|
|
WO/2022/176954A1 |
Disclosed is a radioactive metal complex. The radioactive metal complex has a radioactive metal element and a ligand derived from a compound represented by formula (1). The radioactive metal element is 89Zr or 225Ac. (1) [In formula (1...
|
|
WO/2022/177002A1 |
[Problem] To provide a novel compound promising as a probe for a boron neutron capture therapy (BNCT). [Solution] A compound represented by general formula (I) below or a salt thereof.
|
|
WO/2022/170218A1 |
Disclosed herein are methods of synthesizing compounds of the formula (I) wherein the variables are defined herein. Also provided are compounds produced using these methods. In some aspects, the methods provided herein may be used to ins...
|
|
WO/2022/166993A1 |
Disclosed in the present invention are a novel boron carrier, a preparation method and a pharmaceutical formulation thereof; in particular, the present invention relates to 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-D]-1,2,3,5-tetrazine-8
-ca...
|
|
WO/2022/161453A1 |
The present invention provides an organic metal complex and an organic optoelectronic component comprising same, specifically, an organic electroluminescent diode, where the structure of the organic metal complex is as represented by for...
|
|
WO/2021/202536A9 |
Described herein is an improved wavelength conversion film with composite materials that have improved quantum efficiency and color gamut. The film includes narrow FWHM green and red emitting dyes.
|
|
WO/2022/163377A1 |
Provided is a photosensitizer which has a specific structure, and has higher sensitivity than existing photosensitizers when light irradiation causes a rapid change from hydrophilicity to hydrophobicity. The present invention pertains to...
|
|
WO/2022/158762A1 |
An organic electroluminescent device of an embodiment comprises a first electrode, a second electrode, and a light-emitting layer disposed between the first electrode and the second electrode, wherein the light-emitting layer comprises a...
|
|
WO/2022/154114A1 |
[Problem] To provide a material utilizable as a catalyst for reactions including hydrosilylation. [Solution] Provided is a composite comprising a transition metal complex and a support on which the transition metal complex is supported, ...
|
|
WO/2022/152215A1 |
Provided is an organic compound, comprising a structure as represented by chemical formula (1). Also provided is an organic mixture, comprising at least one first compound and at least one second compound, wherein the first compound comp...
|
|
WO/2022/150132A1 |
The present disclosure describes highly soluble activators for use in olefin polymerization processes. These activators are ionic ammonium borates and have the general formula [Ar(ER1R2H)(R3)][tetrakis(perfluoroaryl)borate] where Ar is a...
|
|
WO/2022/144501A1 |
A tracer compound, or a pharmaceutically acceptable salt or solvate thereof is disclosed, the tracer compound having a structure comprising of a tetrazine moiety, a zwitterion moiety and a linker moiety, the linker moiety linking togethe...
|
|
WO/2022/144228A1 |
The present invention relates to a compound having formula (I) as well as to the use of such as a dye sensitizer. The present invention also relates to a dye sensitized solar cell comprising at least one compound of formula (I) as dye se...
|
|
WO/2022/145267A1 |
The present invention is: a thin film-forming starting material for atomic layer deposition, wherein said starting material contains an aluminum compound as represented by general formula (1); a method for producing thin films that uses ...
|
|
WO/2022/145775A1 |
The present invention relates to: a polycyclic compound represented by chemical formula I; and an organic light emitting device which comprises a first electrode, a second electrode and at least one organic layer provided between the fir...
|
|
WO/2022/145774A1 |
The present invention provides a novel compound, represented by chemical formula 1, which: can be used as a material for the organic material layer of an organic light emitting device; can be used in a solution process; and can improve l...
|
|
WO/2022/146123A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2022/146277A1 |
The present invention provides usage of boric acid in brittle bone disease treatment. In the present invention, moreover, there is a new brittle bone disease (osteogenesis imperfecta) in-vitro model for observing the effect of boric acid...
|
|
WO/2022/145773A1 |
The present invention provides a novel compound, expressed by chemical formula 1, that can be used as material for an organic material layer of a light-emitting device as well as in a solution process, the novel compound improving, in th...
|
|
WO/2022/139763A1 |
The present invention relates to tri(2-dimethyl-R-oxy-silicone) borate compound and synthesis method thereof. More particularly a flame retardant compound which is easy to manufacture, low cost, and suitable for industrial production is ...
|
|
WO/2022/135550A1 |
Provided are a compound as represented by formula I or a pharmaceutically acceptable salt thereof, and applications of the compound in preparing a medicament for preventing and/or treating a PDE-related disorder.
|
|
WO/2022/138822A1 |
The present invention relates to an organic electroluminescent element comprising a positive electrode, a negative electrode, a light-emitting layer, and a hole injection layer, wherein: the light-emitting layer is provided between the p...
|
|
WO/2022/133529A1 |
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and ...
|
|
WO/2022/139513A1 |
The present specification provides a compound of formula 1 and an organic light emitting device comprising same.
|
|
WO/2022/135913A1 |
In particular, the invention relates to a mechanochromic and mechanofluorochromic compound, which has the formula (F) in which: R 1 is selected from: - a linear or branched C1-C4 alkyl chain, and preferably tertiobutyl; a C1-C22 alkoxy c...
|
|
WO/2022/137156A1 |
The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The invention also provides pharmaceutical compositions comprising the compounds, and methods for using the compoun...
|
|
WO/2022/139525A1 |
The present specification provides an organic light-emitting device comprising an emission layer including: a compound represented by chemical formula 1; and a compound represented by chemical formula H.
|
|
WO/2022/138790A1 |
A composition for forming a luminescent layer of an organic electroluminescent element that includes a polycyclic heterocyclic compound represented by formula (1), a compound represented by formula (20), and an organic solvent. Provided ...
|
|
WO/2022/129966A1 |
The present invention relates to a catalytic process for the partial reduction of esters or lactones to silyl acetals, which upon hydrolysis give aldehydes, using silanes as reducing agents, preferably triethylsilane (TESH) or 1,1,3,3-te...
|
|
WO/2022/127193A1 |
Provided are an electrolyte containing a nitrogen-based salt structure, a preparation method therefor and the use thereof. The electrolyte comprises a boron trifluoride salt, and the structure of the boron trifluoride salt is as shown in...
|
|
WO/2022/133097A1 |
The disclosure provides processes for preparing spiro derivatives, in particular (2R,5S)-7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]p
yrimidin-2-yl]-1,7- diazaspiro[4.4]nonan-6-one, as well as intermediates for use in said proces...
|
|
WO/2022/130796A1 |
Provided are: a photoacid generator that effectively generates acid even when there is a high concentration of a substance such as a colorant that attenuates or shields irradiated light, and even when the film thickness is great and a li...
|
|
WO/2022/131780A1 |
The present invention relates to a novel compound having excellent light-emitting ability and to an organic electroluminescent element comprising same. When the compound according to the present invention is used as an organic material l...
|
|
WO/2022/133064A1 |
Disclosed herein are heterocyclic compounds that inhibit the binding of menin and MLL or MLL fusion proteins. Also described are specific irreversible inhibitors of menin-MLL interaction. Also disclosed are pharmaceutical compositions th...
|
|
WO/2022/131230A1 |
The purpose of the present invention is to provide a borate compound which is useful as a co-catalyst that is used for polymerization of olefins or dienes. The present invention relates to: a borate compound which is represented by formu...
|
|
WO/2022/129508A1 |
The present invention concerns a family of organometallic compounds of formula (I) and its use to obtain contrast media applicable in various diagnostic imaging techniques such as X-ray, MRI, PET or SPECT or combinations of these techniq...
|
|
WO/2022/133420A1 |
The present invention describes novel boron containing pyrazole compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as J...
|
|
WO/2022/131768A1 |
The present invention relates to a novel compound with an excellent light-emitting capacity, and an organic electroluminescence element comprising same, wherein the compound according to the present invention, when used in an organic mat...
|
|
WO/2022/023496A9 |
The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorop...
|
|
WO/2022/121920A1 |
Disclosed are a boron-nitrogen compound represented by formula (I) or (II), a composition containing the compound and an application thereof in the field of organic electroluminescence. Also disclosed is a method for preparing a boron-ni...
|
|
WO/2022/121951A1 |
Disclosed are a boron-nitrogen compound of formula I or II, a composition containing the compound, and the use of the compound and composition in the field of organic electroluminescence. Further disclosed is a method for preparing the b...
|
|
WO/2022/124174A1 |
Provided are: a metal-containing additive containing a β-diketonatometal complex and having excellent storage stability; a crosslinkable-polymer composition; and a crosslinked-polymer material, a metallic member, and a wire harness whic...
|
|
WO/2022/122431A1 |
A novel method of making trialkylaluminum compounds and trialkylaluminum obtained thereby via exposing a solution of aluminum to an alkylating agent.
|
